U.S. Markets open in 1 hr, 20 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,318.16 | -14.28 | -0.14% |
| NASDAQ | 2,146.04 | -10.78 | -0.50% |
| S&P 500 | 1,091.38 | -3.52 | -0.32% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
| Day Low | 5.51 12:44 PM EST | |
|---|---|---|
| Day High | 5.69 09:30 AM EST |
|
| Range | 0.18 |
| Volume | 537,571 | |
|---|---|---|
| 30-Day Avg Vol | 326,000 |
|
| Difference | 64.90% |
| Market Cap | 211.77 M | |
|---|---|---|
| Mkt Cap Chg | -382,958 |
| Shares Out | 38.29 M | |
|---|---|---|
| % Shrs Traded | 1.40% | |
| 1yr EPS Est | -0.383 |
| 52-Wk Low | 4.98 | |
|---|---|---|
| 52-Wk High | 10.10 |
|
| Range | 5.12 |
| Prev Close | 5.54 11/19/09 | |
|---|---|---|
| Today's Open | 5.55 | |
| Change | 0.18% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.26 M |
| Revenue (LFY) | 17.15 M | |
|---|---|---|
| Earnings (LFY) | -18.23 M | |
| Earnings (MRQ) | -5.47 M | |
| Next Earn Est | -0.128 | |
| Next Earnings | 03/15/2010 |
|
| EPS (TTM) | -0.80 | |
| 1yr EPS Growth | 52.12% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -14.00 | |
| PEG Ratio | -0.70 | |
| Return on Equity | -11.30 | |
| Beta | 0.90 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more infoCypress Bioscience explores the swampy waters of functional somatic syndromes, a group of chronic symptom-based disorders that are, on the whole, poorly understood. The biotech company's primary target ... View Full Description

| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.128 3/15/10 | — — |
—
—
|
| Last Quarter | -0.21 9/30/09 | -0.14 9/30/09 |
0.07
Beat
|
| 2 Quarters Ago | -0.24 6/30/09 | -0.23 6/30/09 |
0.01
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 6.07 M | 17.16 M |
| Gross Profit | 5.50 M | 16.89 M |
| Operating Income | -5.72 M | -10.38 M |
| Net Income | -5.47 M | -18.23 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.